Detalhe da pesquisa
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
2.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
3.
PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.
Blood
; 129(8): 1039-1041, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031179
4.
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.
Nat Med
; 24(10): 1499-1503, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30275568
5.
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 24(5): 563-571, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29713085
6.
Author Correction: Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.
Nat Med
; 27(3): 561, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33547459